Search results
Merck Raises 2024 Profit Forecast on Strong Sales of Cancer Drug Keytruda
US News & World Report· 6 days agoKeytruda, the world's top selling drug in 2023, has been Merck's key revenue driver over the past few years and is expected to top $30 billion in sales by 2026 before losing exclusivity toward ...
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
Benzinga via Yahoo Finance· 7 days agoThe investigational...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 5 days agoMerck & Co’s market capitalisation growth of 21% was fuelled by the FDA’s approval of Winrevair, a...
Hack That Paralyzed US Health Care Turns Up Scrutiny on Insurer
Insurance Journal· 1 day agoWhen a cyberattack on Change Healthcare paralyzed much of the US health-care system, some lawmakers...
BioNJ Announces Lineup for BioPartnering Conference
FOX 59 Indianapolis· 6 days agoBioNJ is pleased to host its 14th Annual BioPartnering Conference on Tuesday, May 14, at the Liberty Science Center in Jersey City. Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis ...
Antibiotics Market to Reach $68.22 Billion By 2030 fueled by Rising Antimicrobial Resistance and...
Digital Journal· 2 days agoThe global antibiotics market size is valued at USD 49.51 billion in 2022 and is expected to reach...
Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
Clinical Trials Arena via Yahoo Finance· 2 days agoThe expanded approval of Gilead’s Biktarvy was based on the Phase I trial data showing efficacy in...
20 Countries with the Highest Rates of Stomach Cancer in the World
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the 20 countries with the highest rates of stomach...
APA Corp Leads Smead Value Fund's Q1 2024 Portfolio Adjustments with 0.68% Impact
GuruFocus.com via Yahoo Finance· 6 days agoThe top holdings are notably concentrated in 7.46% in Lennar Corp (NYSE:LEN), 6.75% in D.R. Horton...
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points - Chevron (NYSE:CVX),...
Benzinga· 5 days agoThe U.S. economy grew an annualized 1.6% in the first quarter, marking a notable slowdown from the 3.4% rate in the final quarter of 2023. Merck & Co., ...